Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Cancer|Breast Cancer|Prostate Cancer|Colorectal Cancer|Gastro-oesophageal Cancer
Interventions: DRUG: Aspirin 100mg|DRUG: Aspirin 300mg|DRUG: Placebo 100mg|DRUG: Placebo 300mg
Sponsor: University College, London